Company intelligence / Profile preview

Dey

Napa, California, United Statesdey.org ↗

Ownership: Private
Development stage: Other

Overview

Dey was a leading U.S. specialty pharmaceutical company focused on developing and marketing prescription drug products for respiratory diseases, severe allergic reactions, and psychiatric disorders. Its flagship product included Perforomist® Inhalation Solution for COPD. The company operated as a subsidiary of Mylan Inc., which later rebranded it as Mylan Specialty.

Therapeutic areas: PulmonologyPsychiatryImmunology
Modalities: Small moleculeBiologic (inhalation solutions)
Industry: Biotech

Beyond the preview

Go deeper on Dey.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dey.

Explore the full profile